NEWS
By Frederick N. Rasmussen | October 20, 2009
Dr. Lawrence E. Shulman, former director of the connective tissue division of the Johns Hopkins Medical School who later became the founding director of the National Institutes of Arthritis, Musculoskeletal and Skin Diseases at the National Institutes of Health, died of bladder cancer Oct. 10 at his home in Washington. The former longtime Bellemore Road resident was 90. The son of a physician, Dr. Shulman was born and raised in Brookline, Mass. He was a graduate of Boston Latin School and earned his bachelor's degree in 1941 from Harvard University.
NEWS
April 30, 2008
Seminar focuses on juvenile arthritis Anne Arundel Medical Center (AAMC) and the Arthritis Foundation of Maryland will partner for a Juvenile Rheumatoid Arthritis Seminar from 6 p.m. to 8 p.m. Tuesday at the AAMC Sajak Pavilion, 2001 Medical Parkway. The seminar is free and open to the public. According to the foundation, juvenile arthritis affects nearly 300,000 children in the United States -- 50,000 of them stricken with rheumatoid arthritis. "There are approximately 5,600 children with pediatric arthritis in Maryland alone," said Grace Ban, executive director of the Arthritis Foundation's Southern Maryland branch.
NEWS
By Dennis O'Brien | March 22, 2008
GAITHERSBURG -- Using light waves, polymers and a nuclear reactor, researchers here are investigating a superstrong, experimental gel that might some day turn into a novel treatment for millions of people who suffer from arthritis. Scientists at the National Institute of Standards and Technology have spent two years shooting neutron beams at the mysterious hydrogel, trying to determine why it is almost as strong, flexible and resistant to friction as the cartilage in the human knee. The polymers in the gel - formed when synthetic molecules are struck by ultraviolet light - were developed by researchers at Hokkaido University in Japan in 2003.
NEWS
November 28, 2007
Osiris Therapeutics Inc. Shares rose $1.60, or 16 percent, to $11.84 after the Columbia-based developer of treatments using adult stem cells said its experimental drug Chondrogen eased arthritis pain in the knee.
NEWS
August 19, 2007
Golf fundraiser -- The Arthritis Foundation of Southern Maryland will hold its eighth annual "Get Teed Off at Arthritis" Golf Tournament at 9 a.m. Friday at South River Golf Links, 3451 Solomons Island Road, Edgewater. Registration will begin at 7:30 a.m. and there will be a continental breakfast, lunch, silent auction, raffle and award ceremony. The cost is $195 for an individual, $750 for four, or $875 to include a company tee sign. Registration is required and sponsorships are welcome.
NEWS
By Joe Graedon and Teresa Graedon | July 26, 2007
I'm a nurse in a rural hospital. Some of the people I care for tell me that a bee sting every two years or so will significantly decrease arthritis inflammation and pain. They attribute this remedy to the Chinese who came to this area a hundred years ago to work on the railroads and in the logging industry. "Apitherapy," or bee-venom therapy, for arthritis goes way back in time. There are reports that it was used in ancient Egypt and China. Hippocrates (460-377 B.C.) is purported to have written about bee stings for painful joints.
NEWS
By Holly Selby | July 26, 2007
For some people, simply jogging or playing a friendly game of tennis comes with reminders of the passage of time: creaking knees and aching hips. Although these symptoms often can be treated with rest, therapy and medication, nearly 500,000 Americans each year receive knee replacements, says Dr. Brian Mulliken, a joint replacement specialist at St. Joseph Medical Center/Orthopaedic Associates. Another 300,000 people receive hip replacements. And, as the population ages, that number grows annually.
NEWS
November 24, 2006
Rheumatology Joints may benefit from bone drug A drug that strengthens aging bones may also protect patients' joints from osteoarthritis, according to a study by a Johns Hopkins University rheumatologist. Dr. Clifton Bingham and colleagues studied the effect of risedronate, commonly marketed as Actonel, on a group of 2,483 arthritic men and women from the United States and Europe. Researchers measured the amount of cartilage at the one- and two-year point and used blood tests to look for more cartilage breakdown.
NEWS
By GINA KOLATA | July 30, 2006
Valentin Keller enlisted in an all-German unit of the Union Army in Hamilton, Ohio, in 1862. He was 26, a small, slender man, 5 feet 4 inches tall, who had just become a naturalized citizen. He listed his occupation as tailor. A year later, Keller was honorably discharged, sick and broken. He had a lung ailment and was so crippled from arthritis in his hips that he could barely walk. He died at age 41 of "dropsy," which probably meant that he had congestive heart failure. His 39-year-old wife, Otilia, died a month before him of what her death certificate said was "exhaustion."
NEWS
By JOE GRAEDON AND TERESA GRAEDON | July 14, 2006
My 26-year-old daughter has been on Effexor for more than a year for anxiety. Recently, she forgot a dose, and the next day she experienced what she described as an electrical sensation from her feet to her head. She described it as a "zing." The sensation went away when she took the required dose that evening. She is on the lowest dose of Effexor and would like to stop taking it before getting pregnant. Should she be concerned about stopping this medication? The electrical "zing" she experienced is sometimes mentioned when people describe what happens when they stop taking this or similar drugs.